Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Salona Global Medical Device Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an... |
| 08/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/03/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/21/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 01/17/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
| 01/17/2023 |
8-K
| Quarterly results|
Docs:
|
"Loan and Security Agreement, between Simbex, Mio-Guard and Damar and Pathward, National Association",
"Guaranty, by the Company",
"Salona Global Announces Third Quarter Results, Posts 211% Year-Over-Year Revenue Growth, 231% in Gross Margin Growth, Improved Gross Margin to 33%; Shifts Focus to Higher Margin Revenue Lines SAN DIEGO, January 17, 2023 - Salona Global Medical Device Corporation today announced highlights for the third fiscal quarter of 2023, ending November 30, 2022. The Company posted 211% year-over-year revenue growth, 231% year-over-year gross margin growth, and improved gross margin as a percentage of revenue by 10% over last quarter to 33%. The Company also provided an update on the progress toward closing the recently announced acquisition and its focus to list on a US stock exchange. Salona Global in its current form listed in June 2021 on the TSX Venture Exchange with a plan to become a leading m..." |
|
| 12/19/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ... |
| 12/07/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Salona Global Medical Device Corporation, Investor Presentation December 1, 2022",
"Salona Global Announces Private Placement of up to US$10 Million of Debenture Units San Diego, December 1, 2022 - Salona Global Medical Device Corporation , is pleased to announce that it has entered into an engagement letter with a syndicate of agents pursuant to which the Company intends to offer on a commercially reasonable efforts private placement basis a minimum of 3,500 and a maximum of 10,000 debenture units at a price of US$1,000 per Debenture Unit, for aggregate gross proceeds of up to US$10,000,000. Each Debenture Unit will consist of US$1,000 principal amount of 10.0% unsecured subordinated debentures and 1,000 common share purchase warrants of the Company. Each Debenture shall mature on the date which is 60 months from the closing of the Offering and shall bear interest at a r..." |
|
| 12/05/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"Asset Purchase Agreement, by and among Biodex Medical Systems, Inc., Salona Global Medical Device Corporation, and Salona Bio Acquisition, LLC",
"Salona Global Executes Binding Agreement to Acquire the Physical Medicine Assets of Biodex Medical Systems, Inc. ____________________ SAN DIEGO, November 29, 2022 - Salona Global Medical Device Corporation has executed a definitive asset purchase agreement to acquire the physical medicine assets of Biodex Medical Systems, Inc. . As part of the acquisition, at the closing the parties will execute a two-year contract manufacturing agreement with Biodex, which together with the Acquired Assets are expected to generate $26 million annually. The trailing 12-month revenues for the Acquired Assets were $18 million with gross margins of approximately 30%. The Supply Agreement is expected to generate 15% gross margins. Between cash, assets on the balance sheet and its existing debt facility the Co..." |
|
| 10/17/2022 |
10-Q
| Quarterly Report for the period ended August 31, 2022 |
| 10/17/2022 |
8-K
| Quarterly results|
Docs:
|
"Salona Global Announces Second Quarter Results, Posts 153% Year-Over-Year Revenue Growth, 152% in Gross Profit Growth; Builds $18.5M Order Book Backlog SAN DIEGO, October 17, 2022 -- Salona Global Medical Device Corporation today announced highlights for the second fiscal quarter of 2023, ending August 31, 2022. Financial statements for the quarter will be posted today post market closing. Additionally, the Company reported a record order book backlog of $18,500,000 across all its subsidiaries. Financial and Business Headlines Revenues 153% year-over-year growth in revenues, building quarterly revenues to $10,044,239, as compared to $3,973,773 for the same quarter in the prior year. 300% year-over-year increase in total cash receipts for the second quarter, taking in approximately $13.6 m..." |
|
| 10/07/2022 |
8-K
| Quarterly results |
| 09/29/2022 |
8-K
| Appointed a new director|
Docs:
|
"Salona Global Announces Closing of Acquisition; Provides Update on Large Acquisition; Highlights for the Quarter Ending August 30, 2022 SAN DIEGO, September 26, 2022 -- Salona Global Medical Device Corporation announced today that it closed on its previously announced acquisition of DaMar Plastics Inc. , a plastics manufacturing business. The Company also provided an update on the progress of the previously announced large potential acquisition candidate. Together, the deals, in the event the second acquisition closes, are expected to grow SGMD's annual revenue run rate by nearly 80%. Additionally, the company announced highlights of its second quarter, ending August 30, 2022. Finally, Luke Faulstick has been appointed as an Executive Director to the Company's Board of Directors. Closing ..." |
|
| 08/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/29/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Salona Global Expands Management Team to Scale for Growth; Appoints New Chief Financial Officer for Salona, President for SDP Unit; Executes National Sales Distribution Agreement with Digitsole ____ SAN DIEGO, August 22, 2022 -- Salona Global Medical Device Corporation announced that, in line with its rapid growth, it has appointed an experienced public company executive as Chief Financial Officer and promoted an operational executive as President of South Dakota Partners, Inc. , one of the Company's operating subsidiaries. Additionally, the Company has executed a national sales distribution agreement with Digitsole U.S Inc. . Dennis Nelson has been appointed CFO of Salona Global, effective August 29, 2022. Most recently he was Corporate Controller of Manscaped Holdings, LLC based in San ...",
"Salona Global Issues Stock Options to CFO ____ SAN DIEGO, August 29, 2022 -- Salona Global Medical Device Corporation , announces the issuance to Dennis Nelson, its Chief Financial Officer of options to acquire an aggregate of 200,000 Common Shares of the Company at an exercise price of $0.69 per share . The Options have been issued under the Company's 2021 Amended and Restated Stock Option Plan, and they are subject to the terms thereof and are exercisable as follows: Options to acquire 66,666 Common Shares are exercisable, at any time and from time to time, commencing on each of the first, second, and third anniversary of the date of issuance through August 29, 2027. The Options and underlying Common Shares will be subject to a TSX Venture Exchange four month hold period. For more inform..." |
|
| 07/29/2022 |
8-K
| Quarterly results |
| 07/21/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/19/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/14/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 06/09/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
10-K
| Annual Report for the period ended February 28, 2022 |
| 04/05/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 02/25/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
8-K
| Quarterly results |
| 01/28/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Salona Global Medical Device Corporation Announces $4 Million Bought Deal Private Placement San Diego, California - January 27, 2022 - Salona Global Medical Device Corporation , is pleased to announce that it has entered into an agreement with a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase for resale, on a bought deal private placement basis an aggregate of 7,280,000 units at a price of $0.55 per Unit for aggregate gross proceeds to the Company of $4,004,000 . In addition, the Company has granted the Underwriters an option, to purchase up to an additional 1,092,000 Units, for additional gross proceeds of up to $600,600, exercisable in whole or in part at any time up to 48 hours prior to the closing date of the Offering. The Units will be offered prim..." |
|
| 01/24/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/19/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/14/2022 |
10-Q
| Quarterly Report for the period ended November 30, 2021 |
| 01/13/2022 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 12/09/2021 |
8-K
| Quarterly results |
|
|
|